Contact
searchSearch
HMP Global

News

angina
ACC.24: ORBITA-COSMIC - Coronary Sinus Reducer Relieves Angina, But How It Works Remains Unclear
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from...
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from...
The trial focused on patients...
04/09/2024
Cath Lab Digest
refractory angina
ACC.24: Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
04/09/2024

Shockwave Medical News

Shockwave Medical News
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
REDUCER-I is a post-market,...
04/09/2024
Cath Lab Digest
nonvalvular atrial fibrillation
ACC.24: PIONEER AF-PCI Clinical Trial Finds XARELTO (rivaroxaban) Reduces Risk of Clinically Significant Bleeding and Net Adverse Clinical Events or Rehospitalization
04/09/2024

Johnson & Johnson News

Johnson & Johnson News
A new analysis of data from the PIONEER AF-PCI clinical trial demonstrates that XARELTO® (rivaroxaban) is associated with a reduced risk of clinically significant bleeding (CSB), and net adverse clinical events (NACE; a composite of...
A new analysis of data from the PIONEER AF-PCI clinical trial demonstrates that XARELTO® (rivaroxaban) is associated with a reduced risk of clinically significant bleeding (CSB), and net adverse clinical events (NACE; a composite of...
A new analysis of data from the...
04/09/2024
Cath Lab Digest
aorto-iliac occlusive disease
Getinge iCast Covered Stent System Considered Medically Necessary for Treatment of Iliac Arterial Occlusive Disease
04/09/2024

Getinge News

Getinge News
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a...
04/09/2024
Cath Lab Digest
Endovascular Imaging
ACC.24: IVUS-DCB - Intravascular Ultrasound Outperforms Angiography for PAD Treatment
04/08/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“IVUS is more accurate than angiography in measuring vessel dimensions. It facilitates achieving sufficient vessel lumen diameters and aids in evaluating the response of the target lesion to treatment,” said Young-Guk Ko, MD, the study’s lead...
“IVUS is more accurate than angiography in measuring vessel dimensions. It facilitates achieving sufficient vessel lumen diameters and aids in evaluating the response of the target lesion to treatment,” said Young-Guk Ko, MD, the study’s lead...
“IVUS is more accurate than...
04/08/2024
Cath Lab Digest
Heart Valve Disease Awareness
New Survey Uncovers Lack of Awareness Around Heart Valve Disease and Risk Factors Among Women
04/08/2024

Medtronic News

Medtronic News
"When compared to male patients, female patients often present with more advanced symptoms of heart valve disease, highlighting the importance of uncovering how we can best educate women on early warning signs and treatment options sooner,"...
"When compared to male patients, female patients often present with more advanced symptoms of heart valve disease, highlighting the importance of uncovering how we can best educate women on early warning signs and treatment options sooner,"...
"When compared to male patients,...
04/08/2024
Cath Lab Digest
Hypertension
ACC.24: SPYRAL HTN Clinical Program Data Show Durability of Medtronic Renal Denervation System
04/08/2024

Medtronic News

Medtronic News
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
Long-term durability data...
04/08/2024
Cath Lab Digest
CVD Awareness
ACC.24: HUDDLE Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
04/08/2024

Edwards Lifesciences News

Edwards Lifesciences News
Results of the HUDDLE study indicated that the prevalence of hypertension in the 498 screened participants was 83.8%, though only about half (46.5%) self-reported a history of hypertension.
Results of the HUDDLE study indicated that the prevalence of hypertension in the 498 screened participants was 83.8%, though only about half (46.5%) self-reported a history of hypertension.
Results of the HUDDLE study...
04/08/2024
Cath Lab Digest
Mechanical Circulatory Support
ACC.24: DanGer Shock Randomized Controlled Trial Confirms Impella CP Improves Survival in Heart Attack with Cardiogenic Shock
04/08/2024

Abiomed News

Abiomed News
A late-breaking clinical trial confirms routine use of Impella CP in patients who have had a heart attack with STEMI cardiogenic shock reduces 180-day mortality by 12.7%, compared to the control arm (45.8% vs. 58.5%, p=0.04).
A late-breaking clinical trial confirms routine use of Impella CP in patients who have had a heart attack with STEMI cardiogenic shock reduces 180-day mortality by 12.7%, compared to the control arm (45.8% vs. 58.5%, p=0.04).
A late-breaking clinical trial...
04/08/2024
Cath Lab Digest
Cholesterol Therapy
ACC.24: New V-INITIATE Trial Data Show Early Addition of Twice-Yearly* Leqvio (inclisiran) Following Maximally Tolerated Statin Therapy Significantly Reduces LDL-C in ASCVD
04/08/2024

Novartis News

Novartis News
New data demonstrate the early addition of twice-yearly* Leqvio (inclisiran) to maximally tolerated statin therapy, prior to guideline-recommended ezetimibe, in a real-world setting significantly reduced low-density lipoprotein cholesterol...
New data demonstrate the early addition of twice-yearly* Leqvio (inclisiran) to maximally tolerated statin therapy, prior to guideline-recommended ezetimibe, in a real-world setting significantly reduced low-density lipoprotein cholesterol...
New data demonstrate the early...
04/08/2024
Cath Lab Digest

News

Heart Failure
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression
02/12/2025
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic markers of diastolic dysfunction, an important component in the development of heart failure, in...
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic markers of diastolic dysfunction, an important component in the development of heart failure, in...
The retrospective analysis of...
02/12/2025
Cath Lab Digest
lipoprotein(a)
An RNA Inhibitor May Effectively Reduce a High-Risk Type of Cholesterol in Patients With Cardiovascular Disease
02/12/2025
The study reported that higher doses of olpasiran lowered the type of cholesterol called lipoprotein(a) [Lp(a)] by more than 95 percent in participants with atherosclerotic cardiovascular disease.
The study reported that higher doses of olpasiran lowered the type of cholesterol called lipoprotein(a) [Lp(a)] by more than 95 percent in participants with atherosclerotic cardiovascular disease.
The study reported that higher...
02/12/2025
Cath Lab Digest
Heart Failure
JSCAI Article at THT 2025 Sets the Standard for Training Pathways in Interventional Heart Failure
02/11/2025
The article highlights and addresses training gaps to advance the specialty, with an eye toward enabling future trainees to drive innovation and improve outcomes for patients with complex heart failure. 
The article highlights and addresses training gaps to advance the specialty, with an eye toward enabling future trainees to drive innovation and improve outcomes for patients with complex heart failure. 
The article highlights and...
02/11/2025
Cath Lab Digest
Stroke
Philips, World Bank, and Ukraine Ministry of Health Announce Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care. This program – which is already well on its way – aims to address these immense challenges by...
The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care. This program – which is already well on its way – aims to address these immense challenges by...
The demand for stroke care in...
02/10/2025
Cath Lab Digest
AI: Screening
AISAP and Amavita Heart and Vascular Health Bring Cardiac Diagnostics to Underserved Florida Communities with AI-Powered Point-of-Care Ultrasound
02/10/2025
AISAP CARDIO is indicated to provide diagnostic assessment and measurements of several key cardiac structural functional parameters, including: presence of valvular pathology (regurgitations of the mitral, tricuspid, aortic valves and aortic...
AISAP CARDIO is indicated to provide diagnostic assessment and measurements of several key cardiac structural functional parameters, including: presence of valvular pathology (regurgitations of the mitral, tricuspid, aortic valves and aortic...
AISAP CARDIO is indicated to...
02/10/2025
Cath Lab Digest
PAD Centers
$5 Million Gift from Lorraine and Bill Dodero Creates One-of-a-Kind Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute
02/10/2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.
Led by Mehdi Shishehbor DO, MPH,...
02/10/2025
Cath Lab Digest
American Society of Echocardiography
ASE Publishes Updated Guideline Offering Comprehensive, Evidence-Based Recommendations on Ultrasound-Guided Vascular Access Procedures
02/10/2025
The new guideline replaces the original guideline published by the Society on this topic in 2011. This new document provides expert consensus on the best practices and techniques for using ultrasound in vascular access procedures.
The new guideline replaces the original guideline published by the Society on this topic in 2011. This new document provides expert consensus on the best practices and techniques for using ultrasound in vascular access procedures.
The new guideline replaces the...
02/10/2025
Cath Lab Digest
2025 International Stroke Conference (ISC)
DiVERT Stroke Study Uncovers Sex-Based Disparities in Post-Stroke Cardiac Care
02/07/2025
“Standardizing care pathways between neurology and cardiology is one way to help ensure more stroke patients receive guideline-informed cardiac monitoring after a stroke," said David Z. Rose, MD. "Further research on this topic is needed and...
“Standardizing care pathways between neurology and cardiology is one way to help ensure more stroke patients receive guideline-informed cardiac monitoring after a stroke," said David Z. Rose, MD. "Further research on this topic is needed and...
“Standardizing care pathways...
02/07/2025
Cath Lab Digest
GAMEFILM Registry
NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With HeartFlow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players
02/05/2025
The GAMEFILM Registry will enroll approximately 120 NFL alumni. The Registry will leverage coronary computed tomography angiography (CCTA) imaging and insights from the HeartFlow ONE platform (HeartFlow FFRCT and Plaque Analysis) to collect...
The GAMEFILM Registry will enroll approximately 120 NFL alumni. The Registry will leverage coronary computed tomography angiography (CCTA) imaging and insights from the HeartFlow ONE platform (HeartFlow FFRCT and Plaque Analysis) to collect...
The GAMEFILM Registry will...
02/05/2025
Cath Lab Digest
Stroke
Imperative Care Secures FDA 510(k) Clearance for the Zoom System, Including the First Large-Bore .088” Catheter for Aspiration When Used with the Zoom Catheters, for Stroke Treatment
02/03/2025
The Zoom Stroke Solution is a complete stroke system from access through reperfusion designed for fast and effective clot removal in patients presenting with acute ischemic stroke.
The Zoom Stroke Solution is a complete stroke system from access through reperfusion designed for fast and effective clot removal in patients presenting with acute ischemic stroke.
The Zoom Stroke Solution is a...
02/03/2025
Cath Lab Digest

Veterinary Interventional Suite
Dogs With Valve Disease
‘Heart Team’ Offers Hope for Dogs with Valve Disease
02/13/2025
Over the past two years, Dr. Fries and his colleagues have performed more than 40 interventional procedures to repair diseased heart valves in dogs. Chronic valvular disease is a life-limiting condition that affects as much as 7% of older...
Over the past two years, Dr. Fries and his colleagues have performed more than 40 interventional procedures to repair diseased heart valves in dogs. Chronic valvular disease is a life-limiting condition that affects as much as 7% of older...
Over the past two years, Dr....
02/13/2025
Cath Lab Digest
Heart Failure
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression
02/12/2025
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic markers of diastolic dysfunction, an important component in the development of heart failure, in...
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic markers of diastolic dysfunction, an important component in the development of heart failure, in...
The retrospective analysis of...
02/12/2025
Cath Lab Digest
Diabetes and CV Risk
New Study Finds Lower Cardiovascular Risk in Type 1 Diabetes Compared to Type 2 Diabetes
02/12/2025
"Our findings indicate that Type 1 diabetes is associated with a significantly lower risk of cardiovascular events compared to Type 2 diabetes, even after adjusting for various confounders such as age, diabetes control, and kidney function,”...
"Our findings indicate that Type 1 diabetes is associated with a significantly lower risk of cardiovascular events compared to Type 2 diabetes, even after adjusting for various confounders such as age, diabetes control, and kidney function,”...
"Our findings indicate that Type...
02/12/2025
Cath Lab Digest
lipoprotein(a)
An RNA Inhibitor May Effectively Reduce a High-Risk Type of Cholesterol in Patients With Cardiovascular Disease
02/12/2025
The study reported that higher doses of olpasiran lowered the type of cholesterol called lipoprotein(a) [Lp(a)] by more than 95 percent in participants with atherosclerotic cardiovascular disease.
The study reported that higher doses of olpasiran lowered the type of cholesterol called lipoprotein(a) [Lp(a)] by more than 95 percent in participants with atherosclerotic cardiovascular disease.
The study reported that higher...
02/12/2025
Cath Lab Digest
Heart Failure
JSCAI Article at THT 2025 Sets the Standard for Training Pathways in Interventional Heart Failure
02/11/2025
The article highlights and addresses training gaps to advance the specialty, with an eye toward enabling future trainees to drive innovation and improve outcomes for patients with complex heart failure. 
The article highlights and addresses training gaps to advance the specialty, with an eye toward enabling future trainees to drive innovation and improve outcomes for patients with complex heart failure. 
The article highlights and...
02/11/2025
Cath Lab Digest
Stroke
Philips, World Bank, and Ukraine Ministry of Health Announce Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care. This program – which is already well on its way – aims to address these immense challenges by...
The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care. This program – which is already well on its way – aims to address these immense challenges by...
The demand for stroke care in...
02/10/2025
Cath Lab Digest
AI: Screening
AISAP and Amavita Heart and Vascular Health Bring Cardiac Diagnostics to Underserved Florida Communities with AI-Powered Point-of-Care Ultrasound
02/10/2025
AISAP CARDIO is indicated to provide diagnostic assessment and measurements of several key cardiac structural functional parameters, including: presence of valvular pathology (regurgitations of the mitral, tricuspid, aortic valves and aortic...
AISAP CARDIO is indicated to provide diagnostic assessment and measurements of several key cardiac structural functional parameters, including: presence of valvular pathology (regurgitations of the mitral, tricuspid, aortic valves and aortic...
AISAP CARDIO is indicated to...
02/10/2025
Cath Lab Digest
PAD Centers
$5 Million Gift from Lorraine and Bill Dodero Creates One-of-a-Kind Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute
02/10/2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.
Led by Mehdi Shishehbor DO, MPH,...
02/10/2025
Cath Lab Digest
American Society of Echocardiography
ASE Publishes Updated Guideline Offering Comprehensive, Evidence-Based Recommendations on Ultrasound-Guided Vascular Access Procedures
02/10/2025
The new guideline replaces the original guideline published by the Society on this topic in 2011. This new document provides expert consensus on the best practices and techniques for using ultrasound in vascular access procedures.
The new guideline replaces the original guideline published by the Society on this topic in 2011. This new document provides expert consensus on the best practices and techniques for using ultrasound in vascular access procedures.
The new guideline replaces the...
02/10/2025
Cath Lab Digest
2025 International Stroke Conference (ISC)
DiVERT Stroke Study Uncovers Sex-Based Disparities in Post-Stroke Cardiac Care
02/07/2025
“Standardizing care pathways between neurology and cardiology is one way to help ensure more stroke patients receive guideline-informed cardiac monitoring after a stroke," said David Z. Rose, MD. "Further research on this topic is needed and...
“Standardizing care pathways between neurology and cardiology is one way to help ensure more stroke patients receive guideline-informed cardiac monitoring after a stroke," said David Z. Rose, MD. "Further research on this topic is needed and...
“Standardizing care pathways...
02/07/2025
Cath Lab Digest

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use